Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Transition Therapeutics Inc (NASDAQ:TTHI)

2.19
Delayed Data
As of 9:39am ET
 +0.01 / +0.46%
Today’s Change
1.95
Today|||52-Week Range
9.30
-67.97%
Year-to-Date
No recent news for Transition Therapeutics Inc.

Today’s Trading

Previous close2.18
Today’s open2.18
Day’s range2.18 - 2.19
Volume4,208
Average volume (3 months)179,391
Market cap$87.0M
Dividend yield--
Data as of 9:39am ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)-74,855.56%
Earnings growth (this year)-52.28%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratio--
Price/Sales--
Price/Book1.43

Competitors

 Today’s
change
Today’s
% change
ERBERBA Diagnostics Inc0.000.00%
CGIXCancer Genetics Inc-0.25-2.33%
GALTGalectin Therapeutic...+0.03+1.19%
GBSNUGreat Basin Scientif...-0.33-2.02%
Data as of 9:41am ET, 07/31/2015

Financials

Next reporting dateSeptember 28, 2015
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$0.00
Annual profit (last year)-$20.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Tony F. Cruz
President &
Chief Operating Officer
Carl Damiani
Corporate headquarters
Toronto, Ontario

Forecasts